Far-UVC Light May Prevent Infections in Catheters, Cardiac Drivelines

Far-UVC light, delivered by optical fibers can prevent catheter-based and cardiac driveline infections, reports a new study.

A specific wavelength of ultraviolet light, now delivered through light-diffusing optical fibers, is highly effective at killing drug-resistant bacteria in cell cultures, according to a new study led by David J. Brenner, Ph.D., a professor of radiation biophysics at Columbia University Vagelos College of Physicians and Surgeons. The technology is designed to prevent infections around skin-penetrating medical devices, such as catheters or mechanical heart pump drivelines.

New Device Implanted On Heart Prevents Heart Failure
New device termed ‘Therepi’ can be attached directly to the damaged heart, allowing delivery of multiple treatment doses of stem cells to prevent heart failure following a heart attack.

‘Infections from skin-penetrating medical devices such as catheters are are a significant threat and may lead to various complications. Safe UV light, delivered by optical fibers may prevent infections in catheters and cardiac drivelines.’

Tweet it Now

Why it Matters

Infections from skin-penetrating medical devices, including catheters and drivelines for left ventricular assist devices (LVADs), are a major health threat. For example, an estimated 14 to 28 percent of patients with an LVAD develops a driveline skin infection, leading to complications that limit their use as a long-term therapy for heart failure patients. The most serious of these infections are caused by the drug-resistant bacteria MRSA (methicillin-resistant Staphylococcus aureus).

Background

Treating Catheter Infections With Free Fatty Acids
Free fatty acids, made up of compounds similar to those naturally made in the body could be as effective at fighting certain infections as antibiotics, find researchers.

In a previous mouse study, Brenner and his Columbia team demonstrated that a narrow spectrum of far-UVC light, with a wavelength of 207 to 224 nanometers (nm), can kill MRSA bacteria without damaging human skin.

Conventional germicidal UV light, with a wavelength of 254 nm, is also effective at killing bacteria, but it can't be used in health care settings around people because it can harm the skin and eyes.

Antibiotic Used for Acne Cuts Catheter Infections in Dialysis Patients
A medication which is used to treat acne may help ward off serious bacterial infections in kidney patients undergoing dialysis, new research finds.

Far-UVC light is safe for people because it can't penetrate the outer layer of dead skin or the tear layer of the eye, but it's deadly for bacteria, which are much smaller and easier to penetrate.

What's New

FDA Approved Drug for Hepatitis C: New Fixed-Dose Combination - Sofosbuvir, Velpatasvir and Voxilaprevir
The US FDA has approved a fixed-dose combination of sofosbuvir, velpatasvir and voxilaprevir for the treatment of hepatitis C.

The current study was designed to test whether far-UVC light that is transmitted along a thin fiber could be used to disinfect complex tissue shapes, such as the area where a catheter or a driveline enters the skin.

The Columbia team developed a new way to deliver the light, using a laser to send 224 nm far-UVC light through a thin flexible optical fiber. In this study, the fibers were laid directly over tissue cultures containing MRSA bacteria, which were efficiently killed by the far-UVC light diffusing out of the fibers.

What it Means

"Our study suggests that far-UVC light, delivered by optical fibers that can be incorporated into skin-penetrating devices, could be used to prevent catheter-based and driveline infections," said Brenner.

"This application would be used for catheters or drivelines that have to be kept in place for long periods of time, and it's hard to keep the area where they penetrate the skin sterile. Incorporating these thin far-UVC-emitting fibers into the catheter or driveline may be the solution."

What's Next

Studies to determine if the technology can prevent infections around skin-penetrating lines in animal models are currently underway.

Caveats

The study was performed on bacteria in laboratory tissue cultures, not on living animals or human patients. In addition, the technology to make the equipment easily portable and affordable is under development.

Source-Eurekalert